Number of items: 14.
Article
Sherif, Ozlem, Khelwatty, Said, Bagwan, Izhar, Seddon, Alan, Dalgleish, Angus, Mudan, Satvinder and Modjtahedi, Helmout
(2024)
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma.
Oncology Reports, 52(6),
p. 172.
ISSN (print) 1021-335X
Al-Janaby, Tina, Nahi, Narmin, Seddon, Alan, Bagwan, Izhar, Khelwatty, Said and Modjtahedi, Helmout
(2024)
The combination of afatinib with dasatinib or miransertib results in synergistic growth inhibition of stomach cancer cells.
World Journal of Oncology, 15(2),
pp. 192-208.
ISSN (print) 1920-4531
Khan, Tanzeel, Seddon, Alan, Khelwatty, Said, Dalgleish, Angus, Bagwan, Izhar, Mudan, Satvinder and Modjtahedi, Helmout
(2023)
The co-expression of HER family members and CD109 is common in pancreatic cancer.
Medical Research Archives, 11(11),
ISSN (online) 2375-1924
Khelwatty, Said A., Puvanenthiran, Soozana, Essapen, Sharadah, Bagwan, Izhar, Seddon, Alan M. and Modjtahedi, Helmout
(2021)
HER2 expression is predictive of survival in cetuximab treated patients with RAS wild type metastatic colorectal cancer.
Cancers, 13(4),
e638.
ISSN (print) 2072-6694
Khan, Tanzeel, Seddon, Alan M., Dalgleish, Angus G., Khelwatty, Said, Ioannou, Nikolaos, Mudan, Satvinder and Modjtahedi, Helmout
(2020)
Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations : implications for future clinical trials in pancreatic cancer.
Oncology Reports, 44(6),
pp. 2581-2594.
ISSN (print) 1021-335X
Khelwatty, Said Abdullah, Essapen, Sharadah, Bagwan, Izhar, Green, Margaret, Seddon, Alan M. and Modjtahedi, Helmout
(2019)
Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer.
Oncotarget, 10(18),
pp. 1704-1715.
ISSN (online) 1949-2553
Puvanenthiran, S., Essapen, S., Haagsma, B., Bagwan, I., Green, M., Khelwatty, S. A., Seddon, A. M. and Modjtahedi, H.
(2018)
Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer.
Oncotarget, 9,
pp. 19662-19674.
ISSN (online) 1949-2553
Khelwatty, Said, Essapen, Sharadah, Bagwan, Izhar, Green, Margaret, Seddon, Alan and Modjtahedi, Helmout
(2016)
The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer.
Oncotarget, 8(5),
pp. 7666-7677.
ISSN (online) 1949-2553
Khelwatty, Said A., Essapen, Sharadah, Seddon, Alan M., Fan, Zhen and Modjtahedi, Helmout
(2015)
Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers.
British Journal of Cancer, 113(7),
pp. 1010-1019.
ISSN (print) 0007-0920
Khelwatty, Said Abdullah, Essapen, Sharadah, Bagwan, Izhar, Green, Margaret, Seddon, Alan and Modjtahedi, Helmout
(2014)
Co-expression of HER family members in patients with Dukes' C and D colon cancer and their impacts on patient prognosis and survival.
PloS one, 9(3),
e91139.
ISSN (print) 1932-6203
Khelwatty, Said Abdullah, Essapen, Sharadah, Seddon, Alan Michael and Modjtahedi, Helmout
(2013)
Prognostic significance and targeting of HER family in colorectal cancer.
Frontiers in Bioscience, 18(2),
pp. 394-421.
ISSN (print) 1093-9946
Modjtahedi, H., Khelwatty, S.A., Kirk, R.S., Seddon, A.M., Essapen, S., Del Vecchio, C.A., Wong, A.J. and Eccles, S.
(2012)
Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10.
British Journal of Cancer, 106,
pp. 883-888.
ISSN (print) 0007-0920
Conference or Workshop Item
Khelwatty, Said Abdullah, Essapen, Sharadah, Seddon, Alan M., Fan, Zhen and Modjtahedi, Helmout
(2013)
Acquired resistance to anti-EGFR mAb ICR62 or afatinib is accompanied by upregulation of the EGFR in colorectal cancer.
In: 104th Annual Meeting of the American Association for Cancer Research;
6-10 Apr 2013, Washington, U.S.A..
Thesis
Khelwatty, Said Abdullah
(2012)
The biological and clinical significance of HER family members and cancer stem cells in colorectal cancer and response to therapeutic interventions.
(PhD thesis), Kingston University,
.
This list was generated on Fri Dec 20 03:20:54 2024 GMT.